Cantor Fitzgerald reiterates Overweight rating on Cabaletta Bio stock
PositiveFinancial Markets

Cantor Fitzgerald has reaffirmed its Overweight rating on Cabaletta Bio stock, signaling confidence in the company's potential for growth. This endorsement is significant as it reflects the firm's belief in Cabaletta's innovative approaches in the biotech sector, which could lead to increased investor interest and potentially higher stock prices.
— Curated by the World Pulse Now AI Editorial System